Synapse

← HIV Therapy

Papers in HIV Therapy

Page 2 · newest first

  1. Transmitted Drug Resistance in Nonsubtype B HIV-1 InfectionHIV Therapy · 2009
  2. HIV-1 Nonsubtype B Distribution Across Certain Resource-Rich CountriesHIV Therapy · 2009
  3. Dendritic Cell Function in HIV InfectionHIV Therapy · 2009
  4. Haart for Children with Treatment FailureHIV Therapy · 2009
  5. Monitoring HIV Drug Resistance in Treatment-Naive Individuals: Molecular Indicators, Epidemiology and Clinical ImplicationsHIV Therapy · 2009
  6. Tesamorelin: A Synthetic Growth Hormone-Releasing Factor Analog for the Treatment of HIV-Associated LipodystrophyHIV Therapy · 2009
  7. Managing HIV Infection in Infants, Children and Adolescents with HAARTHIV Therapy · 2009
  8. Managing HIV Therapy Literacy in Resource-Limited SettingsHIV Therapy · 2009
  9. Future Directions in the Treatment of Hiv–Hbv CoinfectionHIV Therapy · 2009
  10. Clinical Implications of Antiretroviral Pharmacokinetics and Pharmacodynamics in the CNSHIV Therapy · 2009
  11. Clinical Implications of New Findings in HIV Basic ResearchHIV Therapy · 2009
  12. Advances in HIV Care and Treatment in Resource-Poor CountriesHIV Therapy · 2009
  13. HIV/Aids in Private Sector Companies: Cost Impacts and Responses in Southern AfricaHIV Therapy · 2009
  14. Mechanisms of HIV-Related DyslipidemiaHIV Therapy · 2009
  15. Current Situation and Trends of Drug Abuse and Hiv/Aids in ChinaHIV Therapy · 2009
  16. Type I Interferon in HIV Treatment: From Antiviral Drug to Therapeutic TargetHIV Therapy · 2009
  17. Promising Novel Compounds for the Generation of New Anti-Hiv-Rt Therapeutic DrugsHIV Therapy · 2009
  18. Co-Infections and Co-Therapies: Treatment of HIV in the Presence of Hepatitis C and Hepatitis BHIV Therapy · 2009
  19. LEDGF/p75 and Transportin-SR2 are Cellular Cofactors of HIV Integrase and Novel Targets for Antiviral TherapyHIV Therapy · 2009
  20. Inflammation and Coagulation in HIV Infection Contributes Significantly to Patient MortalityHIV Therapy · 2009
  21. Trials and Tribulations of HIV VaccinesHIV Therapy · 2009
  22. Abacavir/Lamivudine Fixed Dose Combination in the Treatment of Patients with HIV InfectionHIV Therapy · 2008
  23. Efficacy and Resistance of Recently Developed Non-Nucleoside Reverse Transcriptase Inhibitors for HIV-1HIV Therapy · 2008
  24. Gene Profiling in HIV/AIDS Patients: Impacts on TherapyHIV Therapy · 2008
  25. HIV Ribonuclease H: Continuing the Search for Small Molecule AntagonistsHIV Therapy · 2008
  26. Hcv Treatment Challenges in Patients Co-Infected with HIVHIV Therapy · 2008
  27. Neurotoxic Dideoxynucleoside Antiretroviral Therapy is Not Associated with Progression of Painful Distal PolyneuropathyHIV Therapy · 2008
  28. Antiretroviral Prophylaxis for the Prevention of HIV Infection: Future Implementation ChallengesHIV Therapy · 2008